A
Based on the article provided, here are three key points regarding the use of stem cells to treat frailty and other conditions:
1. Targeting Frailty at its Biological Roots
Researchers are testing an experimental therapy called laromestrocel, which uses mesenchymal stem cells from young, healthy donors (aged 18 to 45). Unlike traditional lifestyle changes like strength training, this infusion aims to regenerate the vascular system and muscle fibers by inhibiting degenerative enzymes.
2. Significant Improvements in Mobility
In a trial of 148 older adults (aged 74 to 76), a single infusion of stem cells led to a "dose-dependent" improvement in walking endurance. Nine months after treatment, those who received the maximum dose could walk 63 metres further in six minutes than those who received a placebo. This measurement is considered a key indicator of overall health status and longevity.
3. Potential for Spina Bifida Treatment
The technology is also being applied to prenatal care. In a world-first trial, surgeons used a patch of stem cells derived from donated placentas to treat fetuses in the uterus with spina bifida. While traditional surgery merely tucks the spinal cord back into the vertebrae, the addition of stem cells is being studied to see if it can actively promote the growth and repair of spinal tissue before birth.
Would you like me to elaborate on the biomarkers (like sTIE2) mentioned in the text that help identify who might benefit most from these treatments?
No comments:
Post a Comment